Patents by Inventor Yongxiang Zhao
Yongxiang Zhao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240142175Abstract: Disclosed are an unblocking apparatus for a furnace discharging pipe and a use method. The unblocking apparatus includes a rail, a rail car that may move along the rail, an unblocking drive mechanism arranged on the rail car, a heat-unblocking component, a cold-unblocking component, and a material receiving component that is used to receive a blocking material in the discharging pipe, and a drive end of the unblocking drive mechanism is detachably connected with one end of the heat-unblocking component and the cold-unblocking component respectively. The present application effectively handles different blockage situations of the furnace discharging pipe by connecting the unblocking drive mechanism with an unblocking rod capable of heat-unblocking and a drilling rod capable of cold-unblocking, thereby two modes of heat-unblocking and cold-unblocking are performed on the furnace discharging pipe; and the discharging pipe may be unblocked by a remote operation.Type: ApplicationFiled: October 23, 2023Publication date: May 2, 2024Applicants: China Nuclear Sichuan Environmental Protection Engineering Co., Ltd., China Building Materials Academy, China Nuclear Power Engineering Co., Ltd.Inventors: Weidong XU, Yu CHANG, Yongchang ZHU, Hong DUAN, Chunyu TIAN, Wei WU, Debo YANG, Qingbin ZHAO, Shuaizhen WU, Lin WANG, Zhu CUI, Heyi GUO, Maosong FAN, Yuancheng SUN, Jie MEI, Xiaoli AN, Yongxiang ZHAO, Qinda LIU
-
Patent number: 11965010Abstract: Disclosed are a method for preparing a porcine-derived interferon-delta 5 (pIFN-?5) and an application of the pIFN-?5, where the method for preparing pIFN-?5 includes the following steps: step S1, obtaining a DNA fragment containing pIFN-?5 gene through reverse transcription-polymerase chain reaction (RT-PCR) amplification by using the total RNA of pretreated porcine small intestinal epithelial cells IPEC-J2; step S2, inserting the DNA fragment containing pIFN-?5 gene into an exogenous expression vector to construct a recombinant expression vector for expressing the pIFN-?5 gene; and step S3, introducing the recombinant expression vector into a suitable host cell, and driving the host cell to express the pIFN-?5 gene to obtain the pIFN-?5. The recombinant pIFN-?5 protein is used to prepare drugs or preparations for inhibiting infection of porcine epidemic diarrhea virus (PEDV), porcine transmissible gastroenteritis virus (TGEV), porcine delta coronavirus (PDCoV) and porcine rotavirus (PRoV).Type: GrantFiled: April 27, 2023Date of Patent: April 23, 2024Assignee: JIANGSU ACADEMY OF AGRICULTURAL SCIENCESInventors: Baochao Fan, Bin Li, Shiying Song, Xuehan Zhang, Xuejiao Zhu, Jinzhu Zhou, Yongxiang Zhao, Jizong Li, Rongli Guo, Weilu Guo, Xue Zhang
-
Publication number: 20240067573Abstract: The present disclosure provides a ceramic material for a thermal barrier coating and a manufacturing method thereof. A chemical composition of the ceramic material is LaYbZrCeO7. The ceramic material is manufactured by doping LaO1.5, YbO1.5 and CeO2 into ZrO2. A mole ratio of LaO1.5, YbO1.5, CeO2 and ZrO2 is 1:1:1:1. The manufactured ceramic material is in a composite phase structure mainly including a pyrochlore phase and a fluorite phase. The ceramic material according to the present disclosure can effectively inhibit corrosion penetration of molten CMAS in a high temperature environment, which reduces or avoids ceramic cracking and peeling. This better maintains microstructural integrity of the ceramic surface, thereby extending service life of ceramics.Type: ApplicationFiled: August 26, 2022Publication date: February 29, 2024Inventors: Haizhong Zheng, Pengsen Zhao, Yongxiang Geng, Xinpeng Cao, Peifeng Zhou, Yixin Xiao
-
Patent number: 11912643Abstract: A liquid-solid axial moving bed reaction and regeneration apparatus and a solid acid alkylation process by using the liquid-solid axial moving bed reaction and regeneration apparatus.Type: GrantFiled: October 22, 2019Date of Patent: February 27, 2024Assignees: CHINA PETROLEUM & CHEMICAL CORPORATION, RESEARCH INSTITUTE OF PETROLEUM PROCESSING, SINOPECInventors: Lifeng Hu, Shuandi Hou, Junyi Mao, Zhenxing Zhu, Xiaojin Tang, Zheng Liu, Yongxiang Li, Zhihai Zhao
-
Publication number: 20230303651Abstract: Disclosed are a method for preparing a porcine-derived interferon-delta 5 (pIFN-?5) and an application of the pIFN-?5, where the method for preparing pIFN-?5 includes the following steps: step S1, obtaining a DNA fragment containing pIFN-?5 gene through reverse transcription-polymerase chain reaction (RT-PCR) amplification by using the total RNA of pretreated porcine small intestinal epithelial cells IPEC-J2; step S2, inserting the DNA fragment containing pIFN-?5 gene into an exogenous expression vector to construct a recombinant expression vector for expressing the pIFN-?5 gene; and step S3, introducing the recombinant expression vector into a suitable host cell, and driving the host cell to express the pIFN-?5 gene to obtain the pIFN-?5. The recombinant pIFN-?5 protein is used to prepare drugs or preparations for inhibiting infection of porcine epidemic diarrhea virus (PEDV), porcine transmissible gastroenteritis virus (TGEV), porcine delta coronavirus (PDCoV) and porcine rotavirus (PRoV).Type: ApplicationFiled: April 27, 2023Publication date: September 28, 2023Inventors: Baochao FAN, Bin LI, Shiying SONG, Xuehan ZHANG, Xuejiao ZHU, Jinzhu ZHOU, Yongxiang ZHAO, Jizong LI, Rongli GUO, Weilu GUO, Xue ZHANG
-
Publication number: 20220370597Abstract: A recombinant protein and a vaccine composition for porcine epidemic diarrhea (PED) are provided. The recombinant protein is a fusion protein formed by connecting the truncated segment of S protein (Spike protein) from porcine epidemic diarrhea virus (PEDV) in tandem with the Fc fragment of porcine IgG, and the truncated fragment of S protein is preferably selected from N-terminal domain (NTD) with sialic acid binding activity in S1 subunit of S protein, neutralizing epitope domain (COE) and multiple B-cell epitopes in S2 subunit; the vaccine composition contains recombinant protein and adjuvants. The recombinant protein of the application can produce IgG antibody and neutralizing antibody titers of rather high level after immunizing mice, and the proportions of CD3+CD4+, CD3+CD8+ lymphocytes and the concentrations of IFN-? and IL-4 in lymphocytes are significantly increased.Type: ApplicationFiled: January 27, 2022Publication date: November 24, 2022Inventors: Bin Li, Baochao Fan, Danyi Shi, Jinzhu Zhou, Rongli Guo, Kongwang He, Yongxiang Zhao, Xuejiao Zhu, Li Li, Wei Wang, Dandan Wang, Haodan Zhu
-
Patent number: 11504698Abstract: A Ni—Al2O3@Al2O3—SiO2 catalyst with coated structure is provided. The catalyst has a specific surface area of 98 m2/g to 245 m2/g, and a pore volume of 0.25 cm3/g to 1.1 cm3/g. A mass ratio of an Al2O3 carrier to active component Ni in the catalyst is Al2O3:Ni=100:4˜26, a mass ratio of the Al2O3 carrier to an Al2O3—SiO2 coating layer is Al2O3:Al2O3—SiO2=100:0.1˜3, and a molar ratio of Al to Si in the Al2O3—SiO2 coating layer is 0.01 to 1. Ni particles are distributed on a surface of the Al2O3 carrier in an amorphous or highly dispersed state and have a grain size less than or equal to 8 nm, and the coating layer is filled among the Ni particles.Type: GrantFiled: January 25, 2018Date of Patent: November 22, 2022Assignee: SHANXI UNIVERSITYInventors: Yongxiang Zhao, Haitao Li, Lili Zhao, Hongxi Zhang, Zijin Sun, Yongzhao Wang
-
Publication number: 20210348189Abstract: Provided is a primate disease model construction method based on fast gene edition, which including (a) constructing a sgRNA expression plasmid by using a gRNA oligonucleotide and a pX330 plasmid; (b) injecting the sgRNA expression plasmid prepared in step (a) into a hepatic portal vein of a primate animal by using a biopsy needle until liver cells become cancerous for obtaining a primate disease model. The sgRNA expression plasmid constructed by the gRNA oligonucleotide and pX330 plasmid can be directly injected into the primate liver tissue, so as to construct a tumor model rapidly.Type: ApplicationFiled: September 20, 2018Publication date: November 11, 2021Inventor: YONGXIANG ZHAO
-
Patent number: 10609598Abstract: A base station includes multiple edge nodes and a central node. The edge nodes are configured to perform communication with a user equipment, and execute baseband processing and mutual conversion between baseband data and radio data, in which the multiple edge nodes belong to one or more edge node groups, and each edge node group includes at least one edge node. The central node is configured to perform communication with the multiple edge nodes, manage the multiple edge nodes, and perform resource sharing so that resources are shared by the multiple edge nodes. The base station is divided into two levels of architecture, namely, a central node and an edge node, and the central node implements resource sharing so that resources are shared by the edge nodes, so that a resource sharing degree in the base station is enhanced.Type: GrantFiled: February 17, 2017Date of Patent: March 31, 2020Assignee: Huawei Technologies Co., Ltd.Inventors: Wangjun Wu, Jun Zhou, Peng Lan, Ziqiang Wang, Jun Xia, Yongxiang Zhao, Jingyu Wang, Nengwu Xiang, Ni Ma
-
Publication number: 20200009538Abstract: A Ni—Al2O3@Al2O3—SiO2 catalyst with coated structure is provided. The catalyst has a specific surface area of 98 m2/g to 245 m2/g, and a pore volume of 0.25 cm3/g to 1.1 cm3/g. A mass ratio of an Al2O3 carrier to active component Ni in the catalyst is Al2O3:Ni=100:4˜26, a mass ratio of the Al2O3 carrier to an Al2O3—SiO2 coating layer is Al2O3:Al2O3—SiO2=100:0.1˜3, and a molar ratio of Al to Si in the Al2O3—SiO2 coating layer is 0.01 to 1. Ni particles are distributed on a surface of the Al2O3 carrier in an amorphous or highly dispersed state and have a grain size less than or equal to 8 nm, and the coating layer is filled among the Ni particles.Type: ApplicationFiled: January 25, 2018Publication date: January 9, 2020Inventors: Yongxiang ZHAO, Haitao LI, Lili ZHAO, Hongxi ZHANG, Zijin SUN, Yongzhao WANG
-
Patent number: 10080797Abstract: Provided are an oncolytic heterologous recombinant Newcastle disease virus (NDV), preparation method and application thereof. The heterologous recombinant NDV can express alpha (1,3) galactosyltransferase (?1,3GT). The ?1,3GT is the protein represented by the flowing B1) and B2): B1) the protein has an amino acid sequence of SEQ ID No.1; and B2) the protein is derived from B1) and has a function of ?1,3GT obtained by substituting and/or deleting and/or adding one or more amino acid residue(s) in the amino acid sequence represented by SEQ ID No.1. The recombination NDV can be used for tumor treatment.Type: GrantFiled: August 23, 2016Date of Patent: September 25, 2018Inventor: Yongxiang Zhao
-
Publication number: 20170164239Abstract: A base station includes multiple edge nodes and a central node. The edge nodes are configured to perform communication with a user equipment, and execute baseband processing and mutual conversion between baseband data and radio data, in which the multiple edge nodes belong to one or more edge node groups, and each edge node group includes at least one edge node. The central node is configured to perform communication with the multiple edge nodes, manage the multiple edge nodes, and perform resource sharing so that resources are shared by the multiple edge nodes. The base station is divided into two levels of architecture, namely, a central node and an edge node, and the central node implements resource sharing so that resources are shared by the edge nodes, so that a resource sharing degree in the base station is enhanced.Type: ApplicationFiled: February 17, 2017Publication date: June 8, 2017Applicant: HUAWEI TECHNOLOGIES CO., LTD.Inventors: Wangjun WU, Jun ZHOU, Peng LAN, Ziqiang WANG, Jun XIA, Yongxiang ZHAO, Jingyu WANG, Nengwu XIANG, Ni MA
-
Publication number: 20170106079Abstract: Provided are an oncolytic heterologous recombinant Newcastle disease virus (NDV), preparation method and application thereof. The heterologous recombinant NDV can express alpha (1,3) galactosyltransferase (?1,3GT). The ?1,3GT is the protein represented by the flowing B1) and B2): B1) the protein has an amino acid sequence of SEQ ID No.1; and B2) the protein is derived from B1) and has a function of ?1,3GT obtained by substituting and/or deleting and/or adding one or more amino acid residue(s) in the amino acid sequence represented by SEQ ID No.1. The recombination NDV can be used for tumor treatment.Type: ApplicationFiled: August 23, 2016Publication date: April 20, 2017Inventor: Yongxiang Zhao
-
Patent number: 9615402Abstract: A base station includes multiple edge nodes and a central node. The edge nodes are configured to perform communication with a user equipment, and execute baseband processing and mutual conversion between baseband data and radio data, in which the multiple edge nodes belong to one or more edge node groups, and each edge node group includes at least one edge node. The central node is configured to perform communication with the multiple edge nodes, manage the multiple edge nodes, and perform resource sharing so that resources are shared by the multiple edge nodes. The base station is divided into two levels of architecture, namely, a central node and an edge node, and the central node implements resource sharing so that resources are shared by the edge nodes, so that a resource sharing degree in the base station is enhanced.Type: GrantFiled: May 23, 2012Date of Patent: April 4, 2017Assignee: HUAWEI TECHNOLOGIES CO., LTD.Inventors: Wangjun Wu, Jun Zhou, Peng Lan, Ziqiang Wang, Jun Xia, Yongxiang Zhao, Jingyu Wang, Nengwu Xiang, Ni Ma
-
Patent number: 9499798Abstract: Disclosed in the present invention is a method for inducing the fusion of a dendritic cell with a tumour cell, in the fusion process, successively adding an amount of polyethylene glycol and collagen to induce cell fusion highly efficiently, wherein polyethylene glycol can make the lipid molecules of the plasma membrane at the contact point between the two cells disperse and recombine, and then the cells fuse due to the mutual affinity between the bilayer membranes at the interface of the two cells and the surface tension between each other. The collagen can retrench the cell membrane and repair the cell membrane after fusion, thereby forming stable fusion cells highly efficiently, so it is suitable for the production of specific biological products such as tumour vaccines and monoclonal antibodies etc.Type: GrantFiled: March 7, 2013Date of Patent: November 22, 2016Inventor: Yongxiang Zhao
-
Patent number: 9271134Abstract: Embodiments of the present invention disclose a method for data transmission, which is used to increase resource utilization. The method according to the embodiments of the present invention includes: receiving, by a media processing device, a service request sent by a user equipment, where the media processing device is located at a radio access network where the user equipment is located; obtaining, by the media processing device, service data corresponding to the service request; obtaining, by the media processing device, air interface resource information of a cell where the user equipment is located and transmission resource information; and performing, by the media processing device, content adaptation and bit rate selection on the service data according to the obtained air interface resource information and transmission resource information. The embodiments of the present invention further disclose a system and a relevant device for data transmission.Type: GrantFiled: February 11, 2013Date of Patent: February 23, 2016Assignee: HUAWEI TECHNOLOGIES CO., LTD.Inventors: Jingyu Wang, Junyi Wu, Yongxiang Zhao, Mingsheng Qian, Anni Wei, Hui Wang, Liebin Cai
-
Publication number: 20150252331Abstract: Disclosed in the present invention is a method for inducing the fusion of a dendritic cell with a tumour cell, in the fusion process, successively adding an amount of polyethylene glycol and collagen to induce cell fusion highly efficiently, wherein polyethylene glycol can make the lipid molecules of the plasma membrane at the contact point between the two cells disperse and recombine, and then the cells fuse due to the mutual affinity between the bilayer membranes at the interface of the two cells and the surface tension between each other. The collagen can retrench the cell membrane and repair the cell membrane after fusion, thereby forming stable fusion cells highly efficiently, so it is suitable for the production of specific biological products such as tumour vaccines and monoclonal antibodies etc.Type: ApplicationFiled: March 7, 2013Publication date: September 10, 2015Inventor: Yongxiang Zhao
-
Patent number: 8854968Abstract: The present invention discloses a communication network, device and method. The communication method includes the following steps: a Mobile Broadband Edge (MBB-Edge) node sends a traffic offloading indication to a NodeB according to a traffic offloading policy; and the NodeB directs User Plane (UP) data of a Packet Switched (PS) service to a Public Data Network (PDN) through a fixed broadband bearer network of an offloading path according to the traffic offloading indication. The present invention increases the transmission efficiency of PS services.Type: GrantFiled: June 1, 2011Date of Patent: October 7, 2014Assignee: Huawei Technologies Co., Ltd.Inventors: Yongxiang Zhao, Lian Yang, Wenyuan Yong
-
Publication number: 20120230282Abstract: A base station includes multiple edge nodes and a central node. The edge nodes are configured to perform communication with a user equipment, and execute baseband processing and mutual conversion between baseband data and radio data, in which the multiple edge nodes belong to one or more edge node groups, and each edge node group includes at least one edge node. The central node is configured to perform communication with the multiple edge nodes, manage the multiple edge nodes, and perform resource sharing so that resources are shared by the multiple edge nodes. The base station is divided into two levels of architecture, namely, a central node and an edge node, and the central node implements resource sharing so that resources are shared by the edge nodes, so that a resource sharing degree in the base station is enhanced.Type: ApplicationFiled: May 23, 2012Publication date: September 13, 2012Inventors: Wangjun WU, Jun ZHOU, Peng LAN, Ziqiang WANG, Jun XIA, Yongxiang ZHAO, Jingyu WANG, Nengwu XIANG, Ni MA
-
Publication number: 20120099438Abstract: A method, device and system for transmitting packet service data are provided. The method includes the steps of: receiving the packet service data transmitted by a user equipment; determining the packet service data to be uninstalled in the packet service data according to the service uninstall strategy of the user equipment; and transmitting the packet service data to be uninstalled to the packet data network via a metropolitan-area network and an internet protocol (IP) backbone network. By applying this method, the problem in the prior art is overcome, thereby saving the operation and maintenance cost of the packet network.Type: ApplicationFiled: December 28, 2011Publication date: April 26, 2012Applicant: Huawei Technologies Co., Ltd.Inventors: Shujuan Wang, Yongxiang Zhao, Ming Li, Minchang Yang, Wenyuan Yong, Shangyi Qin, Yu Shao, Wei Gu, Guangwei Wang, Xiaoying Zhao